表紙
市場調查報告書

全球非類鴉片物質止痛貼片市場:產業分析、規模、佔有率、成長率、趨勢、預測

Non-opioid Pain Patch Market (Patch Type - Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches; Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

出版商 Transparency Market Research 商品編碼 535123
出版日期 內容資訊 英文 163 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球非類鴉片物質止痛貼片市場:產業分析、規模、佔有率、成長率、趨勢、預測 Non-opioid Pain Patch Market (Patch Type - Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches; Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
出版日期: 2017年06月20日內容資訊: 英文 163 Pages
簡介

本報告提供全球非類鴉片物質止痛貼片 (止痛消炎粘貼劑) 市場相關調查分析,產業分析,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等系統性資訊。

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 主要市場指標
  • 市場動態
  • 市場分析與預測
  • 波特的五力分析
  • 市場預測
  • WHO的疼痛梯度
  • 腰痛 (LBP)的盛行率
  • 貼片設計技術:概述

第5章 全球非類鴉片物質止痛貼片市場分析與預測:各貼片類型

  • 簡介、定義
  • 主要調查結果/發展
  • 主要趨勢
  • 市場規模預測
  • 市場魅力

第6章 全球非類鴉片物質止痛貼片市場分析與預測:各銷售管道

  • 簡介、定義
  • 主要調查結果/發展
  • 主要趨勢
  • 市場規模預測
  • 市場魅力

第7章 全球非類鴉片物質止痛貼片市場分析與預測:各地區

  • 主要調查結果
  • 政策和法規
  • 市場規模預測
  • 市場魅力

第8章 北美的非類鴉片物質止痛貼片市場分析與預測

第9章 歐洲的非類鴉片物質止痛貼片市場分析與預測

第10章 亞太地區的非類鴉片物質止痛貼片市場分析與預測

第11章 南美的非類鴉片物質止痛貼片市場分析與預測

第12章 中東、非洲的非類鴉片物質止痛貼片市場分析與預測

第13章 競爭情形

  • 競爭矩陣
  • 市場佔有率分析:各企業
  • 企業簡介
    • Acorda Therapeutics, Inc.
    • ALLERGAN
    • Endo International plc
    • GlaxoSmithKline plc
    • 久光製藥
    • IBSA Institut Biochimque SA
    • Mylan N.V.
    • Pfizer, Inc.
    • TEH SENG Pharmaceutical Mfg. Co., Ltd.
    • 帝國製藥
    • 其他
目錄

Title:
Non-opioid Pain Patch Market
(Patch Type - Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches; Distribution Channel - Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies and Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.

Global Non-opioid Pain Patch Market: Overview

Transdermal drug delivery systems (TDDS) is a systemic drug therapy approach which eliminates the risk of gastro-intestinal adverse reactions. The low concentrations of drugs are delivered using these systems as first pass metabolism in the liver is bypassed by using them. The non-opioid pain patch market is witnessing a steady growth due to stable adoption rates. Currently there are three generations of the transdermal drug delivery systems in the market, out of which majority of the FDA approved patches belong to first-generation products. Non-opioid pain patches offer efficient transdermal drug delivery option for the treatment of various pain conditions for a prolonged period of time. The non-opioid pain patches have various functional features such as occlusive backing film prevents inadvertent drug loss, and also improves drug penetration, the protective drug release liner maintains the patch integrity, and prevents accidental exposure before its application.

The market overview section of the report comprises qualitative analysis of the overall non-opioid pain patch market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis for the patch type, and distribution channels, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period which are likely to affect the market dynamics. The WHO pain ladder for pain management treatment has also been provided, along with the percentage prevalence rates of acute pain by region as well as by countries. The snapshot of patch design technologies has been given in the market overview section.

Global Non-opioid Pain Patch Market: Market Segmentation

The global non-opioid pain patch market has been segmented on the basis of patch type, and distribution channels. In terms of patch type, the global non-opioid pain patch market is divided into lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, ketoprofen patches, and others. Furthermore, on the basis of distribution channels, the global non-opioid pain patch market has been classified as hospital pharmacies, online pharmacies, and independent pharmacies & drug stores. The market for these patch type, and distribution channels has been extensively analyzed on the basis of factors such as non-opioid patch usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (US$ million) for each of these segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.

Geographically, the non-opioid pain patch market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of patch type, and distribution channels, along with the CAGR (%) for the forecast period 2016 to 2024.

Global Non-opioid Pain Patch Market: Competitive Landscape

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global non-opioid pain patch market, in terms of percentage share in 2016 (expected) has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global non-opioid pain patch market such as Acorda Therapeutics, Inc., ALLERGAN, Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co.,Inc., IBSA Institut Biochimque SA, Mylan N.V. , Pfizer, Inc., TEH SENG Pharmaceutical Mfg. Co., Ltd., and Teikoku Seiyaku Co., Ltd., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

The global Non-opioid Pain Patch market has been segmented as follows:

Global Non-opioid Pain Patch Market, by Non-opioid Pain Patch Type

  • Lidocaine Patches
  • Diclofenac Patches
  • Methyl Salicylate Patches
  • Capsaicin Patches
  • Ketoprofen Patches
  • Others

Global Non-opioid Pain Patch Market, by Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies & Drug Stores

Global Non-opioid Pain Patch Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Non-opioid Pain Patch Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Non-opioid Pain Patch Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Key Market Indicators
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunity
  • 4.5. Global Non-opioid Pain Patch Market Analysis and Forecasts, 2014-2024
    • 4.5.1. Market Revenue Projections (US$ Mn)
  • 4.6. Porter's Five Force Analysis
  • 4.7. Market Outlook
  • 4.8. WHO Pain Ladder
  • 4.9. Low Back Pain Prevalence (By Region & Countries
  • 4.10. Patch Design Technologies: Snapshot

5. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Non-opioid Pain Patch Type

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Key Trends
  • 5.4. Market Value Forecast By Non-opioid Pain Patch Type, 2014-2024
    • 5.4.1. Lidocaine Patches
    • 5.4.2. Diclofenac Patches
    • 5.4.3. Methyl Salicylate Patches
    • 5.4.4. Capsaicin Patches
    • 5.4.5. Ketoprofen Patches
    • 5.4.6. Others
  • 5.5. Market Attractiveness By Non-opioid Pain Patch Type

6. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Distribution Channels

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value Forecast By Distribution Channels, 2014-2024
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Online Pharmacies
    • 6.4.3. Independent Pharmacies & Drug Stores
  • 6.5. Market Attractiveness By Distribution Channels

7. Global Non-opioid Pain Patch Market Analysis and Forecasts, By Region

  • 7.1. Key Findings
  • 7.2. Policies and Regulations
  • 7.3. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East and Africa
  • 7.4. Market Attractiveness By Country/Region

8. North America Non-opioid Pain Patch Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
    • 8.1.2. Policies and Regulations
    • 8.1.3. Key Trends
  • 8.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014-2024
    • 8.2.1. Lidocaine Patches
    • 8.2.2. Diclofenac Patches
    • 8.2.3. Methyl Salicylate Patches
    • 8.2.4. Capsaicin Patches
    • 8.2.5. Ketoprofen Patches
    • 8.2.6. Others
  • 8.3. Market Value Forecast By Distribution Channels, 2014-2024
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Online Pharmacies
    • 8.3.3. Independent Pharmacies & Drug Stores
  • 8.4. Market Value Forecast By Country, 2014-2024
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Non-opioid Pain Patch Type
    • 8.5.2. By Distribution Channels
    • 8.5.3. By Country

9. Europe Non-opioid Pain Patch Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
    • 9.1.2. Policies and Regulations
    • 9.1.3. Key Trends
  • 9.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014-2024
    • 9.2.1. Lidocaine Patches
    • 9.2.2. Diclofenac Patches
    • 9.2.3. Methyl Salicylate Patches
    • 9.2.4. Capsaicin Patches
    • 9.2.5. Ketoprofen Patches
    • 9.2.6. Others
  • 9.3. Market Value Forecast By Distribution Channels, 2014-2024
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Online Pharmacies
    • 9.3.3. Independent Pharmacies & Drug Stores
  • 9.4. Market Value Forecast By Country, 2014-2024
    • 9.4.1. U.K.
    • 9.4.2. Germany
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Russia
    • 9.4.7. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Non-opioid Pain Patch Type
    • 9.5.2. By Distribution Channels
    • 9.5.3. By Country

10. Asia Pacific Non-opioid Pain Patch Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
    • 10.1.2. Policies and Regulations
    • 10.1.3. Key Trends
  • 10.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014-2024
    • 10.2.1. Lidocaine Patches
    • 10.2.2. Diclofenac Patches
    • 10.2.3. Methyl Salicylate Patches
    • 10.2.4. Capsaicin Patches
    • 10.2.5. Ketoprofen Patches
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Distribution Channels, 2014-2024
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Online Pharmacies
    • 10.3.3. Independent Pharmacies & Drug Stores
  • 10.4. Market Value Forecast By Country, 2014-2024
    • 10.4.1. India
    • 10.4.2. China
    • 10.4.3. Japan
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Non-opioid Pain Patch Type
    • 10.5.2. By Distribution Channels
    • 10.5.3. By Country

11. Latin America Non-opioid Pain Patch Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
    • 11.1.2. Policies and Regulations
    • 11.1.3.. Key Trends
  • 11.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014-2024
    • 11.2.1. Lidocaine Patches
    • 11.2.2. Diclofenac Patches
    • 11.2.3. Methyl Salicylate Patches
    • 11.2.4. Capsaicin Patches
    • 11.2.5. Ketoprofen Patches
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Distribution Channels, 2014-2024
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Online Pharmacies
    • 11.3.3. Independent Pharmacies & Drug Stores
  • 11.4. Market Value Forecast By Country, 2014-2024
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Non-opioid Pain Patch Type
    • 11.5.2. By Distribution Channels
    • 11.5.3. By Country

12. Middle East and Africa Non-opioid Pain Patch Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
    • 12.1.2. Policies and Regulations
    • 12.1.3. Key Trends
  • 12.2. Market Value Forecast By Non-opioid Pain Patch Type, 2014-2024
    • 12.2.1. Lidocaine Patches
    • 12.2.2. Diclofenac Patches
    • 12.2.3. Methyl Salicylate Patches
    • 12.2.4. Capsaicin Patches
    • 12.2.5. Ketoprofen Patches
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Distribution Channels, 2014-2024
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Online Pharmacies
    • 12.3.3. Independent Pharmacies & Drug Stores
  • 12.4. Market Value Forecast By Country, 2014-2024
    • 12.4.1. South Africa
    • 12.4.2. GCC Countries
    • 12.4.3. Rest of Middle East and Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Non-opioid Pain Patch Type
    • 12.5.2. By Distribution Channels
    • 12.5.3. By Country

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 13.2. Market Share Analysis By Company - 2016 (Expected)
  • 13.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 13.3.1. Acorda Therapeutics, Inc.
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.2. ALLERGAN
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.3. Endo International plc
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.4. GlaxoSmithKline plc
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.5. Hisamitsu Pharmaceutical Co.,Inc.
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.6. IBSA Institut Biochimque SA
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.7. Mylan N.V.
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.8. Pfizer, Inc.
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.9. TEH SENG Pharmaceutical Mfg. Co., Ltd.
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.10. Teikoku Seiyaku Co., Ltd.
      • 13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 13.3.1.2 Financial Overview
      • 13.3.1.3 Product Portfolio
      • 13.3.1.4 SWOT Analysis
      • 13.3.1.5 Strategic Overview
    • 13.3.11. Others

List of Tables

  • Table 01: Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014-2024
  • Table 02: Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 03: Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Region, 2014-2024
  • Table 04: North America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 05: North America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014-2024
  • Table 06: North America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 07: Europe Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country/Sub-region, 2014-2024
  • Table 08: Europe Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014-2024
  • Table 09: Europe Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 10: Asia Pacific Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2014-2024
  • Table 11: Asia Pacific Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014-2024
  • Table 12: Asia Pacific Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 13: Latin America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2014-2024
  • Table 14: Latin America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014-2024
  • Table 15: Latin America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024
  • Table 16: Middle East & Africa Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2014-2024
  • Table 17: Middle East & Africa Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Non-opioid Pain Patch Type, 2014-2024
  • Table 18: Middle East & Africa Non-opioid Pain Patch Market Size (US$ Mn) Forecast, by Distribution Channel, 2014-2024

List of Figures

  • Figure 01: Global Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 02: Global Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
  • Figure 03: Global Lidocaine Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014-2024
  • Figure 04: Global Diclofenac Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014-2024
  • Figure 05: Global Methyl Salicylate Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014-2024
  • Figure 06: Global Capsaicin Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014-2024
  • Figure 07: Global Ketoprofen Patches Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014-2024
  • Figure 08: Global Others Market Revenue (US$ Mn) and
  • Figure 09: Global Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
  • Figure 10: Global Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 11: Global Non-opioid Pain Patch Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2014-2024
  • Figure 12: Global Non-opioid Pain Patch Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2014-2024
  • Figure 13: Global Non-opioid Pain Patch Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacies & Drug Stores, 2014-2024
  • Figure 14: Global Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
  • Figure 15: Global Non-opioid Pain Patch Market Value Share, by Region, 2016 and 2024
  • Figure 16: Global Non-opioid Pain Patch Market Attractiveness, by Region, 2016-2024
  • Figure 17: North America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 18: North America Non-opioid Pain Patch Market Attractiveness, by Country, 2016-2024
  • Figure 19: North America Non-opioid Pain Patch Market Value Share, by Country, 2016 and 2024
  • Figure 20: North America Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
  • Figure 21: North America Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 22: North America Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
  • Figure 23: North America Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
  • Figure 24: Europe Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 25: Europe Non-opioid Pain Patch Market Attractiveness, by Country, 2016-2024
  • Figure 26: Europe Non-opioid Pain Patch Market Value Share, by Country/Sub-region, 2016 and 2024
  • Figure 27: Europe Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
  • Figure 28: Europe Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 29: Europe Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
  • Figure 30: Europe Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
  • Figure 31: Asia Pacific Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 32: Asia Pacific Non-opioid Pain Patch Market Attractiveness, by Country, 2016-2024
  • Figure 33: Asia Pacific Non-opioid Pain Patch Market Value Share, by Country/Sub-Region, 2016 and 2024
  • Figure 34: Asia Pacific Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
  • Figure 35: Asia Pacific Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 36: Asia Pacific Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
  • Figure 37: Asia Pacific Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
  • Figure 38: Latin America Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 39: Latin America Non-opioid Pain Patch Market Attractiveness, by Country, 2016-2024
  • Figure 40: Latin America Non-opioid Pain Patch Market Value Share, by Country/Sub-Region, 2016 and 2024
  • Figure 41: Latin America Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
  • Figure 42: Latin America Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 43: Latin America Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
  • Figure 44: Latin America Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
  • Figure 45: Middle East & Africa Non-opioid Pain Patch Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 46: Middle East & Africa Non-opioid Pain Patch Market Attractiveness, by Country, 2016-2024
  • Figure 47: Middle East & Africa Non-opioid Pain Patch Market Value Share, by Country/Sub-Region, 2016 and 2024
  • Figure 48: Middle East & Africa Non-opioid Pain Patch Market Value Share, by Non-opioid Pain Patch Type, 2016 and 2024
  • Figure 49: Middle East & Africa Non-opioid Pain Patch Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 50: Middle East & Africa Non-opioid Pain Patch Market Attractiveness, by Non-opioid Pain Patch Type, 2016-2024
  • Figure 51: Middle East & Africa Non-opioid Pain Patch Market Attractiveness, by Distribution Channel, 2016-2024
  • Figure 52: Global Non-opioid Pain Patch Market Share, by Company, 2016 (Expected)
Back to Top